D
Axonics, Inc.
AXNX
NASDAQ
D
Sell
7/26/2023Upgraded
Axonics, Inc. (AXNX) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
Axonics, Inc. (AXNX) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
E
Sell
7/11/2023Downgrade
Axonics, Inc. (AXNX) was downgraded to E+ from D- on 7/11/2023 due to a decline in the volatility index and total return index.
Axonics, Inc. (AXNX) was downgraded to E+ from D- on 7/11/2023 due to a decline in the volatility index and total return index.
D
Sell
6/26/2023Upgraded
Axonics, Inc. (AXNX) was upgraded to D- from E+ on 6/26/2023 due to an increase in the volatility index and valuation index.
Axonics, Inc. (AXNX) was upgraded to D- from E+ on 6/26/2023 due to an increase in the volatility index and valuation index.
E
Sell
5/25/2023Downgrade
Axonics, Inc. (AXNX) was downgraded to E+ from D- on 5/25/2023 due to a significant decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0138 to -$0.1904, EBIT declined 750.2% from -$1.48M to -$12.6M, and operating cash flow declined 108.35% from $9.35M to -$781.
Axonics, Inc. (AXNX) was downgraded to E+ from D- on 5/25/2023 due to a significant decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0138 to -$0.1904, EBIT declined 750.2% from -$1.48M to -$12.6M, and operating cash flow declined 108.35% from $9.35M to -$781.
D
Sell
3/14/2023Downgrade
Axonics, Inc. (AXNX) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Axonics, Inc. (AXNX) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Axonics, Inc. (AXNX) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
Axonics, Inc. (AXNX) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
Axonics, Inc. (AXNX) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
Axonics, Inc. (AXNX) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
5/31/2022Upgraded
Axonics, Inc. (AXNX) was upgraded to D from D- on 05/31/2022.
Axonics, Inc. (AXNX) was upgraded to D from D- on 05/31/2022.
D
Sell
5/13/2022Downgrade
Axonics, Inc. (AXNX) was downgraded to D- from D on 5/13/2022 due to a noticeable decline in the total return index, growth index and solvency index. Earnings per share declined from -$0.3373 to -$0.5022, operating cash flow declined 35.29% from -$6.78M to -$9.17M, and EBIT declined 33.11% from -$17.68M to -$23.53M.
Axonics, Inc. (AXNX) was downgraded to D- from D on 5/13/2022 due to a noticeable decline in the total return index, growth index and solvency index. Earnings per share declined from -$0.3373 to -$0.5022, operating cash flow declined 35.29% from -$6.78M to -$9.17M, and EBIT declined 33.11% from -$17.68M to -$23.53M.
D
Sell
5/5/2022Upgraded
Axonics, Inc. (AXNX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
Axonics, Inc. (AXNX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
D
Sell
4/20/2022Downgrade
Axonics, Inc. (AXNX) was downgraded to D- from D on 4/20/2022 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 126.32% from -$2.99M to -$6.78M, and EBIT declined 7.14% from -$16.5M to -$17.68M.
Axonics, Inc. (AXNX) was downgraded to D- from D on 4/20/2022 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 126.32% from -$2.99M to -$6.78M, and EBIT declined 7.14% from -$16.5M to -$17.68M.
D
Sell
11/24/2021Downgrade
Axonics, Inc. (AXNX) was downgraded to D from D+ on 11/24/2021 due to a significant decline in the total return index and volatility index.
Axonics, Inc. (AXNX) was downgraded to D from D+ on 11/24/2021 due to a significant decline in the total return index and volatility index.
D
Sell
11/9/2021Upgraded
Axonics, Inc. (AXNX) was upgraded to D+ from D- on 11/09/2021.
Axonics, Inc. (AXNX) was upgraded to D+ from D- on 11/09/2021.
D
Sell
11/8/2021Downgrade
Axonics, Inc. (AXNX) was downgraded to D- from D+ on 11/8/2021 due to a decline in the solvency index. The quick ratio declined from 10.53 to 9.2.
Axonics, Inc. (AXNX) was downgraded to D- from D+ on 11/8/2021 due to a decline in the solvency index. The quick ratio declined from 10.53 to 9.2.
D
Sell
11/3/2021Upgraded
Axonics, Inc. (AXNX) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the total return index and volatility index.
Axonics, Inc. (AXNX) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the total return index and volatility index.
D
Sell
10/11/2021Downgrade
Axonics, Inc. (AXNX) was downgraded to D from D+ on 10/11/2021 due to a major decline in the total return index and volatility index.
Axonics, Inc. (AXNX) was downgraded to D from D+ on 10/11/2021 due to a major decline in the total return index and volatility index.
D
Sell
9/24/2021Upgraded
Axonics, Inc. (AXNX) was upgraded to D+ from D on 9/24/2021 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 53.28% from -$25.58M to -$11.95M, total revenue increased 33.44% from $34.37M to $45.87M, and EBIT increased 6.93% from -$17.2M to -$16.01M.
Axonics, Inc. (AXNX) was upgraded to D+ from D on 9/24/2021 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 53.28% from -$25.58M to -$11.95M, total revenue increased 33.44% from $34.37M to $45.87M, and EBIT increased 6.93% from -$17.2M to -$16.01M.
D
Sell
3/6/2020Upgraded
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to D from D- on 3/6/2020 due to a large increase in the growth index, total return index and solvency index. Total revenue increased 659.82% from $1.31M to $9.95M, the quick ratio increased from 6.63 to 15.99, and debt to equity declined from 0.23 to 0.11.
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to D from D- on 3/6/2020 due to a large increase in the growth index, total return index and solvency index. Total revenue increased 659.82% from $1.31M to $9.95M, the quick ratio increased from 6.63 to 15.99, and debt to equity declined from 0.23 to 0.11.
D
Sell
10/15/2019Downgrade
Axonics Modulation Technologies, Inc. (AXNX) was downgraded to D- from D on 10/15/2019 due to a substantial decline in the volatility index, growth index and total return index.
Axonics Modulation Technologies, Inc. (AXNX) was downgraded to D- from D on 10/15/2019 due to a substantial decline in the volatility index, growth index and total return index.
D
Sell
8/6/2019Downgrade
Axonics Modulation Technologies, Inc. (AXNX) was downgraded to D from D+ on 8/6/2019 due to a decline in the efficiency index, volatility index and growth index. Net income declined 45.32% from -$13.12M to -$19.06M, earnings per share declined from -$0.4714 to -$0.6821, and EBIT declined 41.49% from -$13.62M to -$19.27M.
Axonics Modulation Technologies, Inc. (AXNX) was downgraded to D from D+ on 8/6/2019 due to a decline in the efficiency index, volatility index and growth index. Net income declined 45.32% from -$13.12M to -$19.06M, earnings per share declined from -$0.4714 to -$0.6821, and EBIT declined 41.49% from -$13.62M to -$19.27M.
D
Sell
6/17/2019Upgraded
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to D+ from E+ on 6/17/2019 due to an increase in the total return index and growth index. Total revenue increased 118.02% from $494 to $1.08M, and earnings per share increased from -$0.4981 to -$0.4714.
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to D+ from E+ on 6/17/2019 due to an increase in the total return index and growth index. Total revenue increased 118.02% from $494 to $1.08M, and earnings per share increased from -$0.4981 to -$0.4714.
E
Sell
4/1/2019Upgraded
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to E+ from E on 4/1/2019 due to a significant increase in the solvency index, volatility index and total return index. The quick ratio increased from 5.81 to 26.93.
Axonics Modulation Technologies, Inc. (AXNX) was upgraded to E+ from E on 4/1/2019 due to a significant increase in the solvency index, volatility index and total return index. The quick ratio increased from 5.81 to 26.93.
E
Sell
1/29/2019None
Axonics, Inc. (AXNX) was downgraded to E from U on 01/29/2019.
Axonics, Inc. (AXNX) was downgraded to E from U on 01/29/2019.
